STOCK TITAN

North Amern Platinum (NOAP) Stock News

NOAP NASDAQ

The NOAP news page on Stock Titan focuses on coverage where Nordic Aqua Partners (NOAP) appears within the public disclosures of Israel Corporation Ltd. ("ILCO"). In ILCO's financial reporting, Nordic Aqua Partners is identified by the symbol NOAP and is included among ILCO's "Other" assets alongside its core holdings. As a result, news that discusses ILCO's portfolio composition, total assets, or changes in its holdings can provide indirect context for NOAP.

ILCO describes itself as a public investment company that owns and invests in companies with established managements and defined go-to markets. Within this framework, NOAP is mentioned as part of the group of equity positions that contribute to ILCO's reported asset base. News items that summarize ILCO's quarterly or annual results may reference Nordic Aqua Partners when listing the components of ILCO's portfolio.

On this page, readers can expect news that highlights how NOAP is presented in ILCO's asset tables and how it fits into the "Other" assets category together with ILCO's larger stakes in ICL Group and AKVA Group. Because the available information is centered on ILCO's perspective, the coverage here will reflect mentions of NOAP in that context rather than standalone corporate announcements from Nordic Aqua Partners.

For investors tracking NOAP through its connection to ILCO, this page can be used as a reference point to follow how Nordic Aqua Partners is described in ILCO's public communications about its investment portfolio and total assets.

Rhea-AI Summary

Israel Corporation (TASE: ILCO) reported third-quarter 2026 results, with net profit attributable to shareholders of $52 million. That was up from $46 million a year earlier, as its share of ICL profit rose to $53 million from $51 million. At September 30, net cash rose to $158 million from $123 million at June 30, and total net assets were $3,248 million.

Israel Corporation committed to tender its entire approximately 18% stake in AKVA Group to Pontos Bidco, subject to the offer terms, at NOK 161 per share, with expected proceeds of approximately USD 110 million. The minimum acceptance condition was met on November 9, but regulatory approvals are still pending. AKVA was advised that closing was anticipated in December 2026, although completion and timing remain uncertain. S&P Maalot reaffirmed Israel Corporation's ilA+ credit rating with a stable outlook on July 26, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Israel Corp (TASE: ILCO, NASDAQ:NOAP) reported Q1 2026 net profit to shareholders of $63m, up from $35m in Q1 2025. ILCO’s share in ICL profit was $56m, versus $40m a year earlier.

Headquarters net cash was $100m at March 31, 2026, compared with $73m at December 31, 2025. Total assets, net, were $3,245m, mainly holdings in ICL, Prodalim and AKVA Group.

Prodalim’s IPO on TASE diluted ILCO’s stake from about 27.5% to 23.26% and generated an $11m capital gain. ILCO’s board approved a $13m dividend, paid April 27, 2026, and decided future reporting will be in English only.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Israel Corporation (TASE:NOAP) reported full-year 2025 results and key corporate actions on March 25, 2026. Net profit to shareholders was $87m in 2025, down from $190m in 2024. ILCO reported net cash $73m and total assets, net $3,520m.

The company completed a ~$118m investment in Prodalim in 2025; Prodalim completed a TASE IPO in Feb 2026, diluting ILCO's holding to ~23.26%. The board approved a dividend of approx. $13m (record April 14, 2026; pay April 27, 2026). ILCO will report in English only going forward.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

Israel Corporation (TASE: ILCO) reported third quarter results for the period ended September 30, 2025. Key items: ILCO share in ICL profit $51m, Prodalim profit $1m, amortization and HQ costs of each, and net profit to shareholders $46m.

Liquidity: ILCO reported financial liabilities $660m and investments in liquid assets $695m (including $8m pledged), leaving a $35m liquid-asset surplus and net cash $45m as of Sept 30, 2025 (up from $26m on June 30, 2025); this net cash reflects a $10m derivatives adjustment reducing economic liabilities.

Balance sheet: total assets include ICL market value $3,550m, Prodalim cost $118m, AKVA market value $62m, other $19m, giving total assets $3,749m and total assets, net $3,794m.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags